Commercial Insight - Community Antibacterials Pipelines wither as generic tidal wave takes its toll available through Bharatbook.com
12/02/2009

Bharatbook.com added a new report on "Commercial Insight Community Antibacterials Pipelines wither as generic tidal wave takes its toll" into its market report catalogue for reselling.

Online PR News – 02-December-2009 – – Commercial Insight Community Antibacterials Pipelines wither as generic tidal wave takes its toll

Research points to this sector, beleaguered by patent expiries, barriers to market entry and uptake, becoming increasingly inclement towards branded drugs. Generic incursion has taken a heavy toll on the market at a number of levels. The volume of key brands facing generic competition makes it even harder for remaining products to court large revenues in the community sector. ( http://www.bharatbook.com/detail.asp?id=86313&rt=Commercial-Insight-Community-Antibacterials-Pipelines-wither-as-generic-tidal-wave-takes-its-toll.html )

Scope of this report

* Analysis of the retail market for antibacterials across Japan, US, France, Italy, Germany Spain and the UK
* Product by product analysis of the key marketed brands with a 10 year forecast
* Assessment of key developments shaping the sector, e.g., generic substitution
* Discussion of opportunities and threats on a general, regional and national level

Research and analysis highlights

The community market for antibiotics is declining at a CAGR of -3% over the 2003 07 period. This is the mark of a sector already saturated by generic product. Over the 2003 07 period generic share of the market has grown from 30% of the market, to 40% of seven major market revenues, and from 56% to 65% of volume share. Aside from the substantial difference in market sizes between the US, Japan and the five major EU markets, the nature of community antibacterial sales across the three territories varies greatly. For example, market shares fluctuate substantially depending on whether volume or value statistics are considered. In 2007, the US accounted for a much higher proportion of value share of the market (57%) than volume share (47%), while relatively speaking, the 5EU accounted for a much lower proportion of value share (27%) by comparison to volume share (37%)pointing to substantial differences in the average cost per standard unit.

Key reasons to read this report

* Learn about the extent of the still expanding generic domination of the sector and how to counter it
* Assess the regional and national differences in terms of class and brand preferences and where the opportunities lie
* Review the changes in class sales that signal the shift in prescribing practices
To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=86313&rt=Commercial-Insight-Community-Antibacterials-Pipelines-wither-as-generic-tidal-wave-takes-its-toll.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook